---
id: 101
title: Bioterrorism Agents and Management
category: clinical_syndromes
subcategory: bioterrorism
tags: [bioterrorism, anthrax, plague, smallpox, botulism, category-A]
difficulty: medium
---

## Question

What are the Category A bioterrorism agents? Use the **"Anthrax, Plague, Smallpox, Botulism, Tularemia, VHF"** framework.

## Answer

### **CDC Category A Bioterrorism Agents:**

**"A-P-S-B-T-V" Mnemonic:**
- **A** = ***Bacillus anthracis*** (Anthrax)
- **P** = ***Yersinia pestis*** (Plague)
- **S** = **Smallpox** (Variola virus)
- **B** = ***Clostridium botulinum*** (Botulism)
- **T** = ***Francisella tularensis*** (Tularemia)
- **V** = **Viral Hemorrhagic Fevers** (Ebola, Marburg, Lassa, etc.)

### **Key Features and Treatment:**

| Agent | Presentation | Treatment | Prophylaxis |
|-------|--------------|-----------|-------------|
| **Anthrax** | **Cutaneous:** Black eschar; **Inhalation:** Mediastinal widening, hemorrhagic mediastinitis | **Ciprofloxacin 400mg IV q12h** + **clindamycin** + **antitoxin** | **Ciprofloxacin 500mg PO BID × 60 days** (post-exposure) |
| **Plague** | **Pneumonic:** Severe pneumonia, hemoptysis, rapid progression | **Streptomycin** OR **gentamicin** OR **doxycycline 100mg IV/PO BID** | **Doxycycline 100mg PO BID × 7 days** (post-exposure) |
| **Smallpox** | **Rash:** Centrifugal (face/extremities), all lesions same stage, fever precedes rash | **Supportive care**, **tecovirimat** (TPOXX) if available | **Vaccination within 3-4 days** (post-exposure) |
| **Botulism** | **Descending paralysis:** Cranial nerves first (diplopia, dysarthria, dysphagia) → limbs | **Antitoxin** (heptavalent botulism antitoxin) + **supportive care** (ventilation) | None |
| **Tularemia** | **Typhoidal:** Fever, hepatosplenomegaly; **Pneumonic:** Pneumonia | **Streptomycin** OR **gentamicin** OR **doxycycline** | **Doxycycline 100mg PO BID × 14 days** (post-exposure) |
| **VHF** | **Fever, bleeding diathesis**, multi-organ failure | **Supportive care**, **ribavirin** (Lassa, CCHF), **remdesivir** (Ebola) | **Contact isolation**, PPE |

## Key Points

### **Anthrax:**
- **Inhalation anthrax:** Most lethal form (mediastinal widening on CXR, hemorrhagic mediastinitis)
- **Treatment:** Ciprofloxacin + clindamycin + **antitoxin** (raxibacumab or obiltoxaximab)
- **Post-exposure prophylaxis:** Ciprofloxacin 500mg PO BID × **60 days** + anthrax vaccine (if available)

### **Plague:**
- **Pneumonic plague:** Most contagious form (person-to-person via droplets)
- **Treatment:** Streptomycin or gentamicin (fluoroquinolones alternative)
- **Isolation:** Droplet precautions × 48h after antibiotics

### **Smallpox:**
- **Eradicated** in 1980 (no natural cases)
- **Rash:** Centrifugal distribution, all lesions same stage (vs varicella = centripetal, different stages)
- **Vaccination:** Effective within 3-4 days post-exposure

### **Botulism:**
- **Descending paralysis** (cranial nerves → limbs)
- **No fever** (distinguishes from Guillain-Barré)
- **Antitoxin** critical (heptavalent botulism antitoxin)

### **Clinical Pearls:**
- **Anthrax:** Mediastinal widening = inhalation anthrax
- **Plague:** Pneumonic = droplet precautions, streptomycin/gentamicin
- **Smallpox:** Centrifugal rash, all lesions same stage
- **Botulism:** Descending paralysis, no fever, requires antitoxin
- **All Category A:** Report to public health immediately

## Sources

- [CDC: Bioterrorism Agents/Diseases 2024]
- [IDSA: Biodefense Guidelines 2023]

## Media

N/A
